Peptide based tumor targeting technology, namely, a synthetic peptide attached via a self immolating chemical linker to an active pharmaceutical drug that specifically delivers active pharmaceutical drugs into the tumor cells while sparing normal tissues utilizing the low pH conditions of the tumor micro environment

Peptide based tumor targeting technology, namely, a synthetic peptide attached via a self immolating chemical linker to an active pharmaceutical drug that specifically delivers active pharmaceutical drugs into the tumor cells while sparing normal tissues utilizing the low pH conditions of the tumor micro environment